Skip to main content


  • AddRemove
  • Build a Report 
Media Coverage

Drugmakers Freed From Generic Reglan Claims In Tenn. Suits

13 August 2012
Litigation & Dispute Resolution partner Hank Bullock and associate Andrew Calica (both New York) briefly mentioned as representing Schwarz Pharma and Alaven Pharmaceuticals in an article reporting that a Tennessee federal judge ruled that Schwarz, Alaven and other brand-name and generic makers of the digestion medication Reglan cannot be held liable for injuries allegedly caused by generic versions of the product.

Related Information

  • Related People
    Henninger S. Bullock
    T +1 212 506 2528
    Andrew J. Calica
    T +1 212 506 2256

The Build a Report feature requires the use of cookies to function properly.  Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently.  If you do not accept cookies, this function will not work.  For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.